ClinicalTrials.Veeva

Menu

Longevity Families of the Netherlands (LOF-NL)

L

Leiden University Medical Center (LUMC)

Status

Enrolling

Conditions

Aging
Extreme Longevity
Longevity
Familial Longevity

Study type

Observational

Funder types

Other

Identifiers

NCT06374069
NL81887.058.23

Details and patient eligibility

About

The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity.

The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.

Enrollment

600 estimated patients

Sex

All

Ages

75+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity
  • Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity

Exclusion criteria

Trial design

600 participants in 2 patient groups

Cases - Enriched for familial longevity
Description:
Siblings of dutch Caucasian descent ages 75 and older
Controls - Non-enriched for familial longevity
Description:
Individuals of dutch Caucasian descent ages 75 and older solely in their family.

Trial contacts and locations

1

Loading...

Central trial contact

(Eline) P. Slagboom, Prof. dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems